15
landing page
Asia Summit 2024
landing page
Public Finance Forum 2022 - Program Details
landing page
Public Finance Forum 2022
panel
Partnering for Patients Forum | Reception and Dinner (Invite only)
Join us for an exclusive gathering for Institute supporters, speakers, and special guests to mar
k our shared commitment to partnering for patients.
+ Read More
panel
Leaders in Health Roundtable (Invite only)
This regular gathering of leaders at Milken Institute events will examine policy priorities and
investments that will be required in the wake of the COVID-19 pandemic to accelerate biomedical innovation and address public health challenges.
+ Read More
video
Dec. 7 at 4:30 pm ET | Is Digital Health a Bridge to Health Equity and Representation?
Systemic health-care inequities exposed by the COVID-19 pandemic included minority under-represent
ation in research and disparities in care.
+ Read More
article
2024 Milken Institute Asia Summit Casts Spotlight on Impactful Ideas and Purposeful Action
SINGAPORE, July 26, 2024—Global think tank Milken Institute announced today the return of its annual
Asia Summit in Singapore.
+ Read More
article
Milken Institute Announces Tech Hub Partners Program to Link Business Leaders and Investors to Regional Tech Innovation Opportunities
July 23, 2024 (Washington, DC)—The Milken Institute announced today the development of a Tech Hub Pa
rtners program to strengthen the network of 31 Regional Innovation and Technology Hubs (Tech Hubs) across the US to link business leader
+ Read More
article
FinTech in Focus — July 23, 2024
In This Newsletter
FinTech for Good
MiCA Comes Online for Stablecoin
Banking on the Future
article
An Update from MI Health—July 2024
In This Issue:
article
FasterCures Quarterly Update—July 2024
In This Newsletter
Highlights from Global Conference
Recent Publications
Policy Updates
FasterCures
Program Updates
+ Read More
article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
+ Read More